高比例血浆复苏未能改善儿童创伤患者生存率
该研究基于美国国防部创伤登记库2001至2013年数据,纳入364例接受大量输血(24小时内血制品≥40 mL/kg)的战伤儿童(<18岁),排除烧伤、溺水、孤立性颅脑创伤及较大青少年。以血浆/浓缩红细胞1:2为界分为低比例组和高比例组,两组24小时全因死亡率(9.2% vs 8.0%,p=0.75)和出院死亡率(21.5% vs 17.1%,p=0.39)均无显著差异。高比例组接受更少浓缩红细胞但更多血浆、血小板及总血制品,住院时间更长。回归分析未显示高比例与死亡率获益相关(HR 2.04,95%CI 0.48-8.73,p=0.34)。作者认为需进一步前瞻性研究确定危重儿童最佳复苏策略。
要点
- 在战伤儿童大量输血中,血浆/浓缩红细胞高比例(>1:2)与低比例(≤1:2)相比,24小时死亡率9.2% vs 8.0%(p=0.75),无显著差异。
- 出院死亡率低比例组21.5% vs 高比例组17.1%(p=0.39),无显著差异。
- 高比例组接受更少浓缩红细胞但更多血浆、血小板及总血制品,且住院时间更长。
- 回归分析显示高比例与死亡率获益无关(HR 2.04,95%CI 0.48-8.73,p=0.34)。
- 作者结论:战伤儿童大量输血中高比例血浆/浓缩红细胞未改善生存,需进一步前瞻性研究确定最佳复苏策略。
适用人群与场景
- 美国国防部创伤登记库2001至2013年收录的战伤儿童创伤患者(<18岁)。
- 纳入标准:接受大量输血(24小时内血制品≥40 mL/kg)且早期死亡前接受任何血制品者。
- 排除标准:烧伤、溺水、孤立性颅脑创伤及较大青少年。
诊断标准与关键阈值
- 大量输血定义:24小时内总血制品≥40 mL/kg。
- 以血浆/浓缩红细胞比值1:2为界分为低比例组(≤1:2)和高比例组(>1:2)。
研究设计与关键结果
- 研究类型:基于美国国防部创伤登记库的回顾性分析,纳入364例符合标准的战伤儿童。
- 主要终点:24小时全因死亡率低比例组9.2% vs 高比例组8.0%(p=0.75),无显著差异;出院死亡率低比例组21.5% vs 高比例组17.1%(p=0.39),无显著差异。
- 次要终点:高比例组接受更少浓缩红细胞但更多血浆、血小板及总血制品,且住院时间更长。
- 回归分析:高比例与死亡率获益无关(HR 2.04,95%CI 0.48-8.73,p=0.34)。
- 在全比值谱分析中未发现明确的死亡率拐点。
证据类型、等级与局限
- 证据类型:回顾性登记库分析(治疗性研究,证据等级III级)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在战伤儿童大量输血中,高比例血浆/浓缩红细胞未改善生存,需进一步前瞻性研究确定危重儿童最佳复苏策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Damage control resuscitation including balanced resuscitation with high ratios of plasma (PLAS) and platelets (PLT) to packed red blood cells (PRBC) improves survival in adult patients. We sought to evaluate the effect of a high ratio PLAS to PRBC resuscitation strategy in massively transfused pediatric patients with combat injuries.
METHODS: The Department of Defense Trauma Registry was queried from 2001 to 2013 for pediatric trauma patients (<18 years). Burns, drowning, isolated head trauma, and older teens were excluded. Those who received massive transfusion (≥40 mL/kg total blood products in 24 hours) and early deaths who received any blood products were then evaluated. Primary outcomes were mortality at 24 hours and in-hospital. Secondary outcomes included blood product utilization over 24 hours, ventilator-free days, intensive care unit-free days, and hospital length of stay.
RESULTS: The Department of Defense Trauma Registry yielded 4,980 combat-injured pediatric trauma patients, of whom 364 met inclusion criteria. Analysis of PLAS/PRBC ratios across the entire spectrum of possible ratios in these patients demonstrated no clear inflection point for mortality. Using a division between low (LO) and high (HI) ratios of PLAS/PRBC 1:2, there was no difference in all-cause mortality at 24 hours (LO, 9.2% vs. HI, 8.0%; p = 0.75) and hospital discharge (LO, 21.5% vs. HI, 17.1%; p = 0.39). HI ratio patients received less PRBC but more PLAS and PLT and more total blood products. Those in the HI ratio group also had longer hospital length of stay. Regression analysis demonstrated no associated mortality benefit with a HI ratio (hazards ratio, 2.04; 95% confidence interval, 0.48-8.73; p = 0.34).
CONCLUSION: In combat-injured children undergoing a massive transfusion, a high ratio of PLAS/PRBC was not associated with improved survival. Further prospective studies should be performed to determine the optimal resuscitation strategy in critically injured pediatric patients.
LEVEL OF EVIDENCE: Therapeutic study, level III.
参考来源
- Cannon JW, Johnson MA, Caskey RC, et al. High ratio plasma resuscitation does not improve survival in pediatric trauma patients. J Trauma Acute Care Surg. 2017. PMID: 28481839. doi:10.1097/TA.0000000000001549
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。